Cite
HARVARD Citation
Weisberg, E. et al. (2019). Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. British journal of haematology. pp. 488-501. [Online].